tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Mohan Naidu, 68 are a BUY (100%).
Analyst Mohan Naidu, carries an average stock price target met ratio of 62.92% that have a potential upside of 21.63% achieved within 423 days. Previously, Mohan Naidu worked at OPPENHEIMER.
Mohan Naidu’s has documented 141 price targets and ratings displayed on 16 stocks. The coverage was on Healthcare, Technology, Financial Services, Industrials, Consumer Cyclical sectors.
Most recent stock forecast was given on OMCL, Omnicell at 11-Dec-2019.
Analyst best performing recommendations are on TRHC (TABULA RASA HEALTHCARE).
The best stock recommendation documented was for OMCL (OMNICELL) at 10/26/2018. The price target of $73 was fulfilled within 12 days with a profit of $8.5 (13.18%) receiving and performance score of 10.98.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 12-Sep-2019
$142
$45.74 (47.52%)
$128
16 days ago
(31-Aug-2026)
20/24 (83.33%)
$45.46 (47.09%)
183
Buy Since 31-Dec-2023
$115
$18.74 (19.47%)
$115
19 days ago
(28-Aug-2026)
3/9 (33.33%)
$18.63 (19.33%)
425
Buy Since 09-Sep-2020
$110
$21.54 (24.35%)
$110
3 months 25 days ago
(22-May-2026)
19/26 (73.08%)
$21.89 (24.84%)
219
Hold Since 13-Nov-2025
$105
$16.54 (18.70%)
$100
5 months 7 days ago
(09-Apr-2026)
15/16 (93.75%)
$20.8 (24.70%)
205
Buy Since 22-May-2025
$100
$11.54 (13.05%)
$117
5 months 29 days ago
(18-Mar-2026)
1/3 (33.33%)
$20.43 (25.68%)
13
